Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Juvela, S.
Right arrow Articles by Hillbom, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Juvela, S.
Right arrow Articles by Hillbom, M.

Stroke, Vol 21, 566-571, Copyright © 1990 by American Heart Association


ARTICLES

Platelet thromboxane release after subarachnoid hemorrhage and surgery

S Juvela, M Kaste and M Hillbom
Departments of Neurosurgery, Helsinki University Central Hospital, Finland.

We studied adenosine diphosphate-induced platelet aggregation and the associated release of thromboxane B2 in platelet-rich plasma from 88 patients with subarachnoid hemorrhage and 26 healthy controls. During the first 3 days after subarachnoid hemorrhage, the patients showed significantly decreased (p less than 0.05) platelet aggregability and thromboxane release relative to the controls, but these effects disappeared in a few days. Platelet count increased for 3 weeks after subarachnoid hemorrhage. Surgery in 67 patients was followed by significant increases in platelet aggregability (p less than 0.05) and thromboxane release (p less than 0.001). Greatest thromboxane release was found in the eight patients showing delayed (postoperative) ischemic deterioration with a permanent neurologic deficit. Although platelet hyperaggregability and increased thromboxane release were particularly prominent in these eight patients, the role of these hematologic parameters in the pathogenesis of delayed ischemic deterioration remains unclear.


This article has been cited by other articles:


Home page
StrokeHome page
Y. Fujii, S. Takeuchi, A. Harada, H. Abe, O. Sasaki, and R. Tanaka
Hemostatic Activation in Spontaneous Intracerebral Hemorrhage
Stroke, April 1, 2001; 32(4): 883 - 890.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. van Gijn and G. J. E. Rinkel
Subarachnoid haemorrhage: diagnosis, causes and management
Brain, February 1, 2001; 124(2): 249 - 278.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. W. Hop, G. J. E. Rinkel, A. Algra, J. W. B. van der Sprenkel, and J. van Gijn
Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage
Neurology, February 22, 2000; 54(4): 872 - 878.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. W. Hop, G. J. E. Rinkel, A. Algra, and J. van Gijn
Initial Loss of Consciousness and Risk of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage
Stroke, November 1, 1999; 30(11): 2268 - 2271.
[Abstract] [Full Text] [PDF]